000			02172 a2200589 4500
005			20250517073017.0
264		0	_c20161213
008			201612s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdv625 _2doi
040			_aNLM _beng _cNLM
100	1		_aAl-Batran, S-E
245	0	0	_aQuality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cApr 2016
300			_a673-9 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aEsophageal Neoplasms _xdrug therapy
650	0	4	_aEsophagogastric Junction _xdrug effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aQuality of Life
650	0	4	_aTreatment Outcome
650	0	4	_aRamucirumab
700	1		_aVan Cutsem, E
700	1		_aOh, S C
700	1		_aBodoky, G
700	1		_aShimada, Y
700	1		_aHironaka, S
700	1		_aSugimoto, N
700	1		_aLipatov, O N
700	1		_aKim, T-Y
700	1		_aCunningham, D
700	1		_aRougier, P
700	1		_aMuro, K
700	1		_aLiepa, A M
700	1		_aChandrawansa, K
700	1		_aEmig, M
700	1		_aOhtsu, A
700	1		_aWilke, H
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 27 _gno. 4 _gp. 673-9
856	4	0	_uhttps://doi.org/10.1093/annonc/mdv625 _zAvailable from publisher's website
999			_c25614139 _d25614139